Skip to main content

Table 1 General characteristics of HCC and HCV cases

From: Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients

 

HCC patients

Control

p value

Age (years)

Mean ± SD

55.7 ± 6.7

42.6 ± 7.4

< 0.001*a

Range

40–76

25–57

Sex

Male

36 (76.6%)

36 (72.0%)

0.605b

Female

11 (23.4%)

14 (28.0%)

  1. HCC hepatocellular carcinoma, HCV hepatitis C virus
  2. aStudent’s t test
  3. bChi-square test
  4. *Statistically significant at p < 0.05